Literature DB >> 25245428

Prescription medication misuse among HIV-infected individuals taking antiretroviral therapy.

Howard Newville1, Jason Roley2, James L Sorensen2.   

Abstract

HIV has become a highly treatable disease due to advances in antiretroviral therapy (ART). Additionally, HIV-infected individuals often take opiates, barbiturates, and benzodiazepines to treat co-occurring conditions, including pain and symptoms of HIV. We sought to examine prescription medication misuse by surveying 295 HIV-infected patients receiving ART. Participants answered questions about their demographics, alcohol and other drug use, psychiatric diagnoses, ART adherence and side effects, and quality of life. Eleven percent of our sample acknowledged prescription medication misuse. In regression analysis, prescription medication misusers were more likely to report any drinking to intoxication (OR=4.31, 95% CI: 1.35-13.76, p=0.013), reported greater severity of ART side effects (OR=1.05, 95% CI: 1.01-1.10, p=0.041), and demonstrated poorer cognitive functioning (OR=0.97, 95% CI: 0.94-0.99, p=0.048) compared to those who did not misuse prescription medications. Special care should be taken by medical providers before prescribing medications that may be abused or diverted. Patients should also be screened for aberrant use, even if not prescribed. ART side effects, cognitive deficits, and alcohol abuse may serve as risk factors or indicators of prescription medication misuse, and should be monitored.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiretroviral therapy; HIV; Prescription medication misuse

Mesh:

Year:  2014        PMID: 25245428      PMCID: PMC4250322          DOI: 10.1016/j.jsat.2014.07.013

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  58 in total

1.  The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: prevalence of co-occurrence in a national sample.

Authors:  Sean Esteban McCabe; James A Cranford; Carol J Boyd
Journal:  Drug Alcohol Depend       Date:  2006-04-18       Impact factor: 4.492

2.  Nonmedical use of opioid analgesics obtained directly from physicians: prevalence and correlates.

Authors:  William C Becker; Daniel G Tobin; David A Fiellin
Journal:  Arch Intern Med       Date:  2011-06-13

3.  Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index.

Authors:  John S Cacciola; Arthur I Alterman; A Thomas McLellan; Yi-Ting Lin; Kevin G Lynch
Journal:  Drug Alcohol Depend       Date:  2006-10-11       Impact factor: 4.492

4.  Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team.

Authors:  D S Metzger; B Koblin; C Turner; H Navaline; F Valenti; S Holte; M Gross; A Sheon; H Miller; P Cooley; G R Seage
Journal:  Am J Epidemiol       Date:  2000-07-15       Impact factor: 4.897

5.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

Review 6.  Alcohol and HIV disease progression: weighing the evidence.

Authors:  Judith A Hahn; Jeffrey H Samet
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

7.  Pain, problem drug use history, and aberrant analgesic use behaviors in persons living with HIV.

Authors:  Jennie C I Tsao; Judith A Stein; Aram Dobalian
Journal:  Pain       Date:  2007-04-20       Impact factor: 6.961

8.  Non-medical use of prescription drugs, polysubstance use, and mental health in transgender adults.

Authors:  Eric G Benotsch; Rick Zimmerman; Laurie Cathers; Shawn McNulty; Juan Pierce; Ted Heck; Paul B Perrin; Daniel Snipes
Journal:  Drug Alcohol Depend       Date:  2013-03-17       Impact factor: 4.492

Review 9.  The cognitive effects of opioids.

Authors:  Mary Ersek; Monique M Cherrier; Steven S Overman; Gordon A Irving
Journal:  Pain Manag Nurs       Date:  2004-06       Impact factor: 1.929

10.  Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates.

Authors:  Pekka Rapeli; Carola Fabritius; Hely Kalska; Hannu Alho
Journal:  BMC Clin Pharmacol       Date:  2011-08-21
View more
  9 in total

Review 1.  Prescription drug abuse: from epidemiology to public policy.

Authors:  R Kathryn McHugh; Suzanne Nielsen; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2014-08-28

2.  Self-Reported Cannabis Use and HIV Viral Control among Patients with HIV Engaged in Care: Results from a National Cohort Study.

Authors:  Anees Bahji; Yu Li; Rachel Vickers-Smith; Stephen Crystal; Robert D Kerns; Kirsha S Gordon; Alexandria Macmadu; Melissa Skanderson; Kaku So-Armah; Minhee L Sung; Fiona Bhondoekhan; Brandon D L Marshall; E Jennifer Edelman
Journal:  Int J Environ Res Public Health       Date:  2022-05-06       Impact factor: 4.614

3.  Social Contact Frequency and Pain among Older Adults with HIV: An Ecological Momentary Assessment Study.

Authors:  Matthew S Herbert; Jennalee S Wooldridge; Emily W Paolillo; Colin A Depp; Raeanne C Moore
Journal:  Ann Behav Med       Date:  2022-02-11

Review 4.  Prescription drug diversion, misuse, and abuse among people living with HIV: a scoping review protocol.

Authors:  Buyisile Chibi; Neusa Fernanda Torres; Tivani P Mashamba-Thompson
Journal:  Syst Rev       Date:  2020-02-12

5.  Prevalence and correlates of prescription drug diversion and misuse among people living with HIV in the eThekwini district, KwaZulu-Natal, South Africa.

Authors:  Buyisile Chibi; Nonhlanhla Yende-Zuma; Tivani P Mashamba-Thompson
Journal:  PLoS One       Date:  2020-12-16       Impact factor: 3.240

6.  Chronic High Risk Prescription Opioid Use Among Persons With HIV.

Authors:  Ana Ventuneac; Gavriella Hecht; Emily Forcht; Bianca A Duah; Shafaq Tarar; Blanche Langenbach; Jay Gates; Demetria Cain; H Jonathon Rendina; Judith A Aberg; David C Perlman
Journal:  Front Sociol       Date:  2021-05-18

7.  Trajectories of Self-Reported Opioid Use Among Patients With HIV Engaged in Care: Results From a National Cohort Study.

Authors:  E Jennifer Edelman; Yu Li; Declan Barry; Jennifer Brennan Braden; Stephen Crystal; Robert D Kerns; Julie R Gaither; Kirsha S Gordon; Ajay Manhapra; Jessica S Merlin; Brent A Moore; Benjamin J Oldfield; Lesley S Park; Christopher T Rentsch; Melissa Skanderson; Emily C Williams; Amy C Justice; Janet P Tate; William C Becker; Brandon D L Marshall
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.771

8.  Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.

Authors:  Noe Garin; Cesar Velasco; Jan T De Pourcq; Belen Lopez; Maria Del Mar Gutierrez; Josep M Haro; Anna Feliu; Maria A Mangues; Antoni Trilla
Journal:  Front Microbiol       Date:  2015-07-14       Impact factor: 5.640

9.  Association Between Diagnoses of Chronic Noncancer Pain, Substance Use Disorder, and HIV-Related Outcomes in People Living With HIV.

Authors:  Cecile M Denis; Knashawn H Morales; Qufei Wu; David S Metzger; Martin D Cheatle
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-01       Impact factor: 3.731

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.